Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein Degraders.

Webb DT, Jones KL, Macabuag N, Bago R, Betts J, Bhattacharyya S, Clifton S, Tinson RAJ, Achara C, Gilbert S, Howell S, Drewry DH, Rogers R, Jones C, Ferguson KR, Bullock AN, Lindsay DM, Kerr WJ, Esmieu W